Trait
SNPs associated with Thyroid Disease, Drug Use Measurement
38 genetic variants across 18 genes have been associated with Thyroid Disease, Drug Use Measurement in published research. Key genes include ARID5B, CASC19, CTLA4.
Associated variants38 total
| rsid | Gene | Effect | Evidence |
|---|---|---|---|
| rs965513 | PTCSC2 | GWAS association (p=3.0e-133) | Major Consortium Study |
| rs7850258 | PTCSC2 | GWAS association (p=2.0e-119) | Major Consortium Study |
| rs9272293 | HLA-DQA1 | GWAS association (p=7.0e-65) | Major Consortium Study |
| rs6679677 | PHTF1 | GWAS association (p=6.0e-63) | Major Consortium Study |
| rs2476601 | PTPN22 | GWAS association (p=3.0e-58) | Major Consortium Study |
| rs11675342 | — | GWAS association (p=6.0e-53) | Major Consortium Study |
| rs17020127 | — | GWAS association (p=1.0e-51) | Major Consortium Study |
| rs11211645 | — | GWAS association (p=7.0e-43) | Major Consortium Study |
| rs10223666 | POLR1C | GWAS association (p=6.0e-26) | Major Consortium Study |
| rs1203946 | — | GWAS association (p=2.0e-25) | Major Consortium Study |
| rs6790260 | LPP | GWAS association (p=5.0e-25) | Major Consortium Study |
| rs1382879 | — | GWAS association (p=7.0e-23) | Major Consortium Study |
| rs4686953 | LPP | GWAS association (p=2.0e-22) | Major Consortium Study |
| rs9472135 | — | GWAS association (p=2.0e-21) | Major Consortium Study |
| rs9497968 | — | GWAS association (p=5.0e-18) | Major Consortium Study |
| rs151213404 | RNASET2 | GWAS association (p=5.0e-16) | Major Consortium Study |
| rs7681551 | LOC107986195 | GWAS association (p=6.0e-16) | Major Consortium Study |
| rs71508903 | ARID5B | GWAS association (p=8.0e-16) | Major Consortium Study |
| rs706778 | IL2RA | GWAS association (p=3.0e-15) | Major Consortium Study |
| rs1655907 | — | GWAS association (p=5.0e-15) | Major Consortium Study |
| rs121912648 | TG | GWAS association (p=7.0e-14) | Major Consortium Study |
| rs4853458 | STAT4 | GWAS association (p=2.0e-13) | Major Consortium Study |
| rs2412973 | HORMAD2 | GWAS association (p=2.0e-13) | Major Consortium Study |
| rs7073236 | — | GWAS association (p=8.0e-13) | Major Consortium Study |
| rs1003342 | HORMAD2 | GWAS association (p=2.0e-12) | Major Consortium Study |
| rs35006079 | CASC19 | GWAS association (p=2.0e-12) | Major Consortium Study |
| rs7861040 | — | GWAS association (p=3.0e-12) | Major Consortium Study |
| rs7508679 | — | GWAS association (p=4.0e-12) | Major Consortium Study |
| rs945635 | FCRL3 | GWAS association (p=2.0e-11) | Major Consortium Study |
| rs11052877 | — | GWAS association (p=4.0e-11) | Major Consortium Study |
| rs61759532 | — | GWAS association (p=4.0e-11) | Major Consortium Study |
| rs10917471 | LOC105376817 | GWAS association (p=4.0e-18) | Major Consortium Study |
| rs3087243 | CTLA4 | GWAS association (p=2.0e-64) | Major Consortium Study |
| rs654537 | — | GWAS association (p=5.0e-23) | Major Consortium Study |
| rs2983511 | — | GWAS association (p=1.0e-23) | Major Consortium Study |
| rs4409785 | — | GWAS association (p=2.0e-14) | Major Consortium Study |
| rs3184504 | SH2B3 | GWAS association (p=4.0e-59) | Major Consortium Study |
| rs17462267 | — | GWAS association (p=2.0e-12) | Major Consortium Study |
Associations aggregated from the GWAS Catalog and curated literature. Informational only — not medical advice.